Home » Topics » Regulatory

Regulatory
RSS

FDA expands indication for FluLaval influenza vaccine

Nov. 22, 2016

European Commission approves Trisenox for first-line treatment of low to intermediate risk APL

Nov. 21, 2016

FDA approves Intrarosa to treat dyspareunia in postmenopausal women

Nov. 18, 2016

European approval for Parsabiv to treat secondary hyperparathyroidism in hemodialysis patients

Nov. 14, 2016

FDA approves Vemlidy to treat chronic HBV infection

Nov. 11, 2016

FDA approves Opdivo for head and neck cancer

Nov. 11, 2016

FDA approves Enbrel to treat children with moderate to severe plaque psoriasis

Nov. 7, 2016

Silvergate announces U.S. availability of Qbrelis

Oct. 27, 2016

FDA issues new approvals in NSCLC for Keytruda

Oct. 25, 2016

FDA approves Zinplava to reduce recurrence of C. difficile infection

Oct. 24, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...